文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > 粒细胞-巨噬细胞集落刺激因子基因转染骨髓基质细胞移植治疗脑缺血
侵权投诉

粒细胞-巨噬细胞集落刺激因子基因转染骨髓基质细胞移植治疗脑缺血

给大脑中动脉闭塞24h模型大鼠缺血边缘区注射粒细胞-巨噬细胞集落刺激因子基因转染的骨髓基质干细胞。结果显示,相比于单纯骨髓基质干细胞移植,接受粒细胞-巨噬细胞集落刺激因子基因转染骨髓基质干细胞移植的脑缺血大鼠,脑梗死体积减少,细胞凋亡数量减少,血管生成因子表达增加,缺血边缘带血管密度增加,神经功能增强

Granulocyte-macrophage colony-stimulating

factor-transfected bone marrow stromal cells for the treatment of ischemic stroke**☆

Xingjian Lin1, Yingdong Zhang1, 2, Weiguo Liu1, Jingde Dong1, Jie Lu1, Qing Di1, Jingping Shi1

1Nanjing Medical University, Affiliated Nanjing Brain Hospital, Department of Neurology, Nanjing 210029, Jiangsu Province, China 2Nanjing Medical University, Affiliated Nanjing First Hospital, Department of Neurology, Nanjing 210029, Jiangsu Province, China

NEURAL REGENERATION RESEARCH Volume 7, Issue 16, June 2012

Cite this article as: Neural Regen Res. 2012;7(16):1220-1227.

粒细胞-巨噬细胞集落刺激因子基因转染骨髓基质细胞移植治疗脑缺血

doc.guandang.net

Abstract

Adult, male, Sprague-Dawley rats were injected with granulocyte-macrophage colony-stimulating factor-transfected bone marrow stromal cells (GM-CSF-BMSCs) into the ischemic boundary zone at 24 hours after onset of middle cerebral artery occlusion. Results showed reduced infarct volume, decreased number of apoptotic cells, improved neurological functions, increased angiogenic factor expression, and increased vascular density in the ischemic boundary zone in rats that underwent GM-CSF-BMSCs transplantation compared with the BMSCs group. Experimental findings

suggested that GM-CSF-BMSCs could serve as a potential therapeutic strategy for ischemic stroke and are superior to BMSCs alone.

Xingjian Lin☆, M.D.,

Associate chief physician, Nanjing Medical University, Affiliated Nanjing Brain Hospital, Department of Neurology, Nanjing 210029, Jiangsu Province, China

Xingjian Lin and Weiguo Liu contributed equally to this paper.

Corresponding author:

Yingdong Zhang, M.D., Chief physician, Nanjing Medical University, Affiliated Nanjing Brain Hospital, Department of Neurology, Nanjing 210029, Jiangsu Province, China; Nanjing Medical University, Affiliated Nanjing First Hospital, Department of Neurology, Nanjing 210029, Jiangsu Province, China zhangyingdong2006@ yahoo.com.cn

Received: 2012-01-29 Accepted: 2012-04-27 (N20111123001/YJ)

Lin XJ, Zhang YD, Liu WG, Dong JD, Lu J, Di Q, Shi JP. Granulocyte-macrophage colony-stimulating

factor-transfected bone marrow stromal cells for the treatment of ischemic stroke. Neural Regen Res. 2012;7(16):1220-1227.

doc.guandang.net

doc.guandang.net

doi:10.3969/j.issn.1673-5374.2012.16.003

Key Words

bone marrow stromal cells; granulocyte-macrophage colony-stimulating factor; gene transfection; ischemic stroke; transplantation; stem cells; neural regeneration

Abbreviations

GM-CSF, granulocyte-macrophage colony-stimulating factor; BMSCs, bone marrow stromal cells; MCAO, middle cerebral artery occlusion; mNSS, modified neurological severity scores

cell proliferation[10-11]. The mechanisms of functional recovery following BMSC

transplantation are more likely due to the release of trophic factors that promote

neural differentiation of BMSCs and cellular integration within injured ischemic sites[10-11]. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a well-known

hematopoietic cytokine and was originally identified because of its ability to stimulate hematopoietic cell differentiation and function[12]. More recently, GM-CSF has attracted attention, because of its effects on neural cell proliferation and differentiation. Previous studies have shown that

exogenous GM-CSF stimulates neuronal progenitor proliferation, prevents neuronal apoptosis, improves functional recovery following experimental spinal cord contusion

INTRODUCTION

Bone marrow stromal cells (BMSCs) exhibit characteristics of multipotential stem cells. BMSCs can be expanded in vitro and induced to differentiate into osteogenic, chondrogenic, adipogenic, and other

mesenchymal lineages[1], such as neuronal cells[2-3]. Recent studies have shown that BMSC transplantation results in therapeutic benefits following traumatic brain injury,

ischemic brain injury, or spinal cord injury[4-8]. However, post-injury transplantations

resulted in central nervous system protein expression in < 20% of transplanted cells[9]. BMSCs provide a stromal microenvironment for hematopoiesis and produce an array of trophic factors and cytokines that influence

1220

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email